Citizens Financial Group Inc Pro Phase Labs, Inc. Transaction History
Citizens Financial Group Inc
- $4.97 Billion
- Q1 2025
A detailed history of Citizens Financial Group Inc transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Citizens Financial Group Inc holds 270,400 shares of PRPH stock, worth $83,824. This represents 0.0% of its overall portfolio holdings.
Number of Shares
270,400Holding current value
$83,824% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRPH
# of Institutions
32Shares Held
2.44MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA408KShares$126,5620.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny286KShares$88,8100.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL237KShares$73,4020.0% of portfolio
-
Sheets Smith Wealth Management208KShares$64,5730.01% of portfolio
-
Geode Capital Management, LLC Boston, MA204KShares$63,0930.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $4.97M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...